Access to treatment of hepatitis C in prison inmates

Digestive Diseases and Sciences

Volumn 54, Issue 6, 2009, Pages 1325-1330

  Strock, Paul ^a   Mossong, Joël ^b   Hawotte, Karine ^a   Arendt, Vic ^a  

^a CENTRE HOSPITALIER DE LUXEMBOURG   (Luxembourg)

^b LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

Epidemiology; Hepatitis C; Prison; Therapy

Indexed keywords

PEGINTERFERON; RIBAVIRIN;

ADULT; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GENOTYPE; HEALTH CARE ACCESS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; PRISONER; PROSPECTIVE STUDY; TREATMENT REFUSAL; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VIRUS LOAD;

ADULT; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEPATITIS C, CHRONIC; HUMANS; LUXEMBOURG; MALE; PRISONERS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 67349190934     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-008-0483-8     Document Type: Article

References (25)

1. EASL International Consensus Conference on hepatitis C. J Hepatol. 1999;31(suppl 1):3-8. doi: 10.1016/S0168-8278(99)80367-5 .
2. MJ Alter D Kruszon-Moran OV Nainan GM McQuillan G Fengxiang LA Moyer 1999 The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 N Engl J Med 341 556 562 (Pubitemid 29384163)
3. AJ Remy 2006 Hepatitis C in prison settings: screening and therapy are improving Presse Med 35 1249 1254
4. A Claudon-Charpentier M Hoibian P Glasser H Lalanne JL Pasquali 2000 Drug addicted inmates of the Elsau prison, Strasbourg, France Rev Med Interne 21 505 509
5. DS Holsen S Harthug H Myrmel 1993 Prevalence of antibodies to hepatitis C virus and association with intravenous drug abuse and tattooing in a national prison in Norway Eur J Clin Microbiol Infect Dis 12 673 676 (Pubitemid 23293225)
6. S Allwright F Bradley J Long J Barry L Thornton JV Parry 2000 Prevalence of antibodies to hepatitis B, hepatitis C and HIV and risk factors in Irish prisoners: result of a national cross sectional survey BMJ. 321 78 82 (Pubitemid 30438479)
7. SM Gore AG Bird SO Cameron SJ Hutchinson SM Burns DJ Goldberg 1999 Prevalence of hepatitis C in prison Q J Med 92 25 32
8. V Hedouin D Gosset 1998 Hepatitis C virus infection in a prison population Gastroenterol Clin Biol 22 55 58
9. C Skipper JM Guy J Parkes P Roderick WM Rosenberg 2003 Evaluation of a prison outreach clinic for the diagnosis and prevention of hepatitis C: implications for the national strategy Gut 52 1500 1504 (Pubitemid 37176732)
10. DS Morrison G Gilchrist 2001 Prison admission health screening as a measure of health needs Health Bull (Edinb) 59 114 119
11. PB Christensen HB Krarup HGM Niesters H Norder J Georgsen 2000 Prevalence and incidence of bloodborne viruses among Danish prisoners Eur J Epidemiol 16 1043 1049
12. RK Fox SL Currie J Evans TL Wright L Tobler B Phelps 2005 Hepatitis C virus infection among prisoners in the California state correctional system Clin Infect Dis 41 177 186 (Pubitemid 40962498)
13. SA Allen AC Spaulding AM Osei LE Taylor AM Cabral JD Rich 2003 Treatment of chronic hepatitis C in a state correctional facility Ann Intern Med 138 187 190 (Pubitemid 36236128)
14. RK Sterling CM Hofmann VA Luketic AJ Sanyal MJ Contos SA Mills 2004 Treatment of chronic hepatitis C virus in the Virginia department of corrections: can compliance overcome racial differences to response? Am J Gastroenterol 99 866 872 (Pubitemid 39090215)
15. E Blanchet G Defossez A Verneau I Ingrand C Silvain M Beauchant 2003 Epidemiology and management of care of hepatitis C infection in the Poitou-Charentes region in 1997 and 2000 Gastroenterol Clin Biol 27 1026 1030 (Pubitemid 37516828)
16. C Hatem A Minello S Bresson-Hadni V Jooste P Evrard B Obert 2005 Is the management of hepatitis C patients appropriate? A population-based study Aliment Pharmacol Ther 21 1007 1015 (Pubitemid 40529735)
17. Y Falck-Ytter H Kale KD Mullen SA Sarbah L Sorescu AJ McCullough 2002 Surprisingly small effect of antiviral treatment in patients with hepatitis C Ann Intern Med 136 288 292 (Pubitemid 34150758)
18. G Narasimhan TN Sargios R Kalakuntla P Homel DJ Clain ND Theise 2006 Treatment rates in patients with chronic hepatitis C after liver biopsy J Viral Hepat 13 783 786 (Pubitemid 44583505)
19. AAM Shaheen RP Myers 2007 Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C-related fibrosis: a systematic review Hepatology 46 912 921 (Pubitemid 47436137)
20. EJ Bini N Bräu S Currie 2005 Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection Am J Gastroenterol 100 1772 1779 (Pubitemid 41648433)
21. AA Butt AC Justice M Skanderson MO Rigsby CB Good C Kent Kwoh 2007 Rate and predictors of treatment prescription for hepatitis C Gut 56 385 389 (Pubitemid 46579770)
22. MW Fried ML Shiffman KR Reddy C Smith G Marinos FL Gonçales Jr 2002 Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975 982
23. M Schaefer A Hinzpeter A Mohmand 2007 Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side-effects Hepatology 46 991 998 (Pubitemid 350144763)
24. TE Wiley M McCarthy L Breidi M McCarthy TJ Layden 1998 Impact of alcohol on the histological and clinical progression of hepatitis C infection Hepatology 28 805 809 (Pubitemid 28405433)
25. BH McGovern A Wurcel AY Kim J Schulze zur Wiesch I Bica MT Zaman J Timm BD Walker GM Lauer 2006 Acute hepatitis C virus infection in incarcerated injection drug users Clin Infect Dis 42 1663 1670 (Pubitemid 43839427)